GP
AGN

GLG Partners’s Allergan plc AGN Stock Holding History

GLG Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100,200
Closed -$31.3M – 525
2015
Q4 		$31.3M Buy
+100,200
New +$29.8M 1% 19
2014
Q2 		– Sell
-50,000
Closed -$10.3M – 444
2014
Q1 		$10.3M Buy
+50,000
New +$9.9M 0.2% 134

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

GLG Partners's AGN Position: Q4 2017 in Review

GLG Partners opened a new position in Allergan plc (AGN) in Q4 2017: 486 shares worth $79K. The stake represents ﹤0.01% of the portfolio and ranks #425 among its holdings. This is a return to the name: GLG Partners previously reported a position in AGN as recently as Q3 2016.

GLG Partners first reported a position in AGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $111M in Q1 2014. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • GLG Partners held 486 shares of Allergan plc worth $79K as of Q4 2017.
  • Allergan plc was a new GLG Partners position in Q4 2017.
  • Allergan plc made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #425 holding.
  • GLG Partners first reported a position in Allergan plc in Q2 2013 and has held it in 13 quarters since.
  • GLG Partners's Allergan plc position peaked at $111M in Q1 2014.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.